GentiBio
Kristin Neff is a seasoned leader in clinical operations with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Clinical Operations at GentiBio since January 2025, Kristin has held significant roles at several prominent companies, including Sanofi, Provention Bio, Anokion, ImmusanT, InVivo Therapeutics, TARIS Biomedical, ConforMIS, HeartWare Inc., and Boston Scientific. Kristin's career is highlighted by positions such as Vice President of Clinical Operations at multiple organizations and Director of Clinical Project Management at leading firms. Kristin holds a Master of Science in Biomedical Engineering from Boston University and a Bachelor of Science in Electrical Engineering from the University of Massachusetts Amherst.
This person is not in the org chart
This person is not in any teams
GentiBio
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.